...
首页> 外文期刊>Scandinavian journal of infectious diseases. >Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
【24h】

Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.

机译:白细胞介素6和C反应蛋白在社区获得性肺炎中的诊断和预后价值。

获取原文
获取原文并翻译 | 示例
           

摘要

The diagnostic and prognostic value of admission serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) was investigated in 203 hospital-treated patients with community-acquired pneumonia (CAP). In serum samples obtained during the first 24 h after admission, IL-6 was detectable in 198 patients (98%), with a median value of 50 ng/l. Ten % of the patients had IL-6 values of 1000 ng/l. A clear positive correlation between IL-6 and CRP was found (r = 0.29, p < 0.0001). Patients with high IL-6 or CRP levels had longer duration of fever, longer hospital stay, and had less often recovered clinically or radiographically on follow-up weeks after discharge. A high IL-6, but not a high CRP, also seemed to be associated with a higher mortality. Bacteremic pneumococcal pneumonia had the highest levels of IL-6 (mean 2852 and median 420 ng/l) and CRP (mean 292 and median 285 mg/l). High IL-6 values were also seen in patients with non-bacteremic pneumococcal pneumonia, while all patients with pneumonia dueto other bacterial, or viral, aetiology had IL-6 levels of < or = 300 ng/l. In conclusion, IL-6 and CRP are promising diagnostic and prognostic tools in the management of CAP. Further studies are needed to establish the usefulness of repeated measurements early in the hospital course of the disease.
机译:研究了203例住院治疗的社区获得性肺炎(CAP)患者的白细胞介素6(IL-6)和C反应蛋白(CRP)的入院血清水平的诊断和预后价值。在入院后最初24小时内获得的血清样本中,有198例患者(98%)可检测到IL-6,中位值为50 ng / l。 10%的患者的IL-6值为1000 ng / l。发现IL-6和CRP之间存在明显的正相关(r = 0.29,p <0.0001)。高IL-6或CRP水平的患者发烧时间更长,住院时间更长,出院后几周的临床或X线摄片很少恢复。高IL-6而不是高CRP似乎也与更高的死亡率有关。细菌性肺炎球菌性肺炎的IL-6(平均2852,中位数420 ng / l)和CRP(平均292,中位数285 mg / l)最高。在非细菌性肺炎球菌性肺炎患者中也观察到高的IL-6值,而所有因其他细菌性或病毒性病因引起的肺炎患者的IL-6水平均≤300 ng / l。总之,IL-6和CRP是CAP管理中有希望的诊断和预后工具。在疾病的医院病程中,需要进一步的研究来确定重复测量的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号